Debt-to-equity of Humacyte, Inc. from 30 Jun 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Humacyte, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2021 to 30 Sep 2025.
  • Humacyte, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was -3163%, a 178% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Humacyte, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -3163% -2026% -178% 30 Sep 2025
Q2 2025 -826% -1919% -176% 30 Jun 2025
Q1 2025 -609% -950% -279% 31 Mar 2025
Q4 2024 -566% -791% -352% 31 Dec 2024
Q3 2024 -1138% -1275% -928% 30 Sep 2024
Q2 2024 1093% +986% +927% 30 Jun 2024
Q1 2024 341% +254% +291% 31 Mar 2024
Q4 2023 225% +129% +136% 31 Dec 2023
Q3 2023 137% +27% +25% 30 Sep 2023
Q2 2023 106% -41% -28% 30 Jun 2023
Q1 2023 87% +818% 31 Mar 2023
Q4 2022 95% +173% 31 Dec 2022
Q3 2022 110% +139% 30 Sep 2022
Q2 2022 148% +153% 30 Jun 2022
Q1 2022 -731% 31 Mar 2022
Q4 2021 -78% 31 Dec 2021
Q3 2021 -29% 30 Sep 2021
Q2 2021 -5% 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.